Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research

Contributed by: Business Wire

Logo

Tags

Health

Infectious Diseases

Health Technology

Research

Science

Pharmaceutical

Biotechnology

Stanford Medicine

More Like This

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases

Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis

Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration

Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay